Inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder of the gastrointestinal (GI) tract that significantly impacts the quality of life of patients.
Current and emerging biomarkers in the management of inflammatory bowel disease
- Post author:
- Post published:September 12, 2024
- Post category:uncategorized